loadpatents
name:-0.037498950958252
name:-0.031059980392456
name:-0.0093550682067871
Fu; Zice Patent Filings

Fu; Zice

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fu; Zice.The latest application filed is for "piperidinone derivatives as mdm2 inhibitors for the treatment of cancer".

Company Profile
9.31.33
  • Fu; Zice - Foster City CA
  • Fu; Zice - Burlingame CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20220169611 - Bartberger; Michael D. ;   et al.
2022-06-02
Heteroaryl-substituted triazoles as APJ receptor agonists
Grant 11,046,680 - Chen , et al. June 29, 2
2021-06-29
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20210179560 - Bartberger; Michael D. ;   et al.
2021-06-17
1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use
Grant 11,021,493 - Allen , et al. June 1, 2
2021-06-01
Triazole furan compounds as agonists of the APJ receptor
Grant 10,736,883 - Brown , et al. A
2020-08-11
1,4-thiazine Dioxide And 1,2,4-thiadiazine Dioxide Derivatives As Beta-secretase Inhibitors And Methods Of Use
App 20200231601 - ALLEN; Jennifer R. ;   et al.
2020-07-23
Triazole Furan Compounds As Agonists Of The Apj Receptor
App 20190275008 - BROWN; Matthew ;   et al.
2019-09-12
Bromotriazole intermediates
Grant 10,344,016 - Dransfield , et al. July 9, 2
2019-07-09
Bromotriazole Intermediates
App 20190100510 - Dransfield; Paul John ;   et al.
2019-04-04
Triazole agonists of the APJ receptor
Grant 10,221,162 - Chen , et al.
2019-03-05
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20190062276 - Bartberger; Michael D. ;   et al.
2019-02-28
Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor
Grant 10,150,760 - Chen , et al. Dec
2018-12-11
Triazole Agonists Of The Apj Receptor
App 20180319773 - CHEN; Ning ;   et al.
2018-11-08
Methods of treating heart failure
Grant 10,058,550 - Chen , et al. August 28, 2
2018-08-28
Compounds For Use In Preparing Heterocyclic Triazole Agonists Of The Apj Receptor
App 20180222895 - Chen; Xiaoqi ;   et al.
2018-08-09
Heterocyclic triazole compounds as agonists of the APJ receptor
Grant 9,988,369 - Chen , et al. June 5, 2
2018-06-05
Triazole agonists of the APJ receptor
Grant 9,868,721 - Chen , et al. January 16, 2
2018-01-16
Intermediates for preparing triazole agonists of the APJ receptor
Grant 9,845,310 - Chen , et al. December 19, 2
2017-12-19
Heterocyclic Triazole Compounds As Agonists Of The Apj Receptor
App 20170320860 - CHEN; Xiaoqi ;   et al.
2017-11-09
Methods Of Treating Heart Failure
App 20170281625 - Chen; Ning ;   et al.
2017-10-05
Methods for preparing triazole agonists of the APJ receptor
Grant 9,751,864 - Chen , et al. September 5, 2
2017-09-05
Triazole agonists of the APJ receptor
Grant 9,745,286 - Chen , et al. August 29, 2
2017-08-29
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20170144971 - BARTBERGER; Michael D. ;   et al.
2017-05-25
Triazole agonists of the APJ receptor
Grant 9,656,997 - Chen , et al. May 23, 2
2017-05-23
Intermediates for preparing triazole agonists of the APJ receptor
Grant 9,656,998 - Chen , et al. May 23, 2
2017-05-23
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
Grant 9,593,129 - Bartberger , et al. March 14, 2
2017-03-14
Triazole agonists of the APJ receptor
Grant 9,573,936 - Chen , et al. February 21, 2
2017-02-21
Triazole Agonists Of The Apj Receptor
App 20170044131 - CHEN; Ning ;   et al.
2017-02-16
Triazole Agonists Of The Apj Receptor
App 20170042897 - Chen; Ning ;   et al.
2017-02-16
Triazole Agonists Of The Apj Receptor
App 20170042872 - CHEN; Ning ;   et al.
2017-02-16
Triazole Agonists Of The Apj Receptor
App 20170042871 - Chen; Ning ;   et al.
2017-02-16
Triazole Agonists Of The Apj Receptor
App 20170035744 - CHEN; Ning ;   et al.
2017-02-09
Triazole Agonists Of The Apj Receptor
App 20170037026 - CHEN; Ning ;   et al.
2017-02-09
Triazole Agonists Of The Apj Receptor
App 20160340336 - Chen; Ning ;   et al.
2016-11-24
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20160137667 - BARTBERGER; Michael D. ;   et al.
2016-05-19
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
Grant 9,296,736 - Bartberger , et al. March 29, 2
2016-03-29
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer
App 20140315895 - Bartberger; Michael D. ;   et al.
2014-10-23
Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions
Grant 8,785,468 - Du , et al. July 22, 2
2014-07-22
Spirocyclic GPR40 modulators
Grant 8,748,462 - Brown , et al. June 10, 2
2014-06-10
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer
App 20140011796 - BARTBERGER; Michael David ;   et al.
2014-01-09
Phenylanaline Amide Derivatives Useful For Treating Insulin-related Diseases And Conditions
App 20120115811 - Du; Xiaohui ;   et al.
2012-05-10
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer
App 20110319378 - BARTBERGER; Michael David ;   et al.
2011-12-29
Substituted biphenyl GPR40 modulators
Grant 8,030,354 - Brown , et al. October 4, 2
2011-10-04
N-aryl pyrazole compounds, compositions, and methods for their use
Grant 8,022,061 - Ogawa , et al. September 20, 2
2011-09-20
Heterocyclic GPR40 modulators
Grant 8,003,648 - Beck , et al. August 23, 2
2011-08-23
Spirocyclic Gpr40 Modulators
App 20110190330 - Brown; Sean P. ;   et al.
2011-08-04
Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
Grant 7,939,538 - Fu , et al. May 10, 2
2011-05-10
Heterocyclic GPR40 modulators
Grant 7,714,008 - Beck , et al. May 11, 2
2010-05-11
Heterocyclic Gpr40 Modulators
App 20100075974 - Beck; Hilary ;   et al.
2010-03-25
Substituted biphenyl GPR40 modulators
Grant 7,572,934 - Brown , et al. August 11, 2
2009-08-11
Asthma and allergic inflammation modulators
Grant 7,541,383 - Fu , et al. June 2, 2
2009-06-02
Substituted biphenyl GPR40 modulators
App 20090111859 - Brown; Sean P. ;   et al.
2009-04-30
N-aryl pyrazole compounds, compositions, and methods for their use
App 20080153778 - Ogawa; Yasuyuki ;   et al.
2008-06-26
Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use
Grant 7,375,102 - Fu , et al. May 20, 2
2008-05-20
Heterocyclic GPR40 Modulators
App 20080090840 - Beck; Hilary ;   et al.
2008-04-17
Asthma and allergic inflammation modulators
App 20080085891 - Fu; Zice ;   et al.
2008-04-10
Asthma and allergic inflammation modulators
Grant 7,321,001 - Fu , et al. January 22, 2
2008-01-22
Imidazolo-related compounds, compositions and methods for their use
Grant 7,271,271 - Fu , et al. September 18, 2
2007-09-18
Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
App 20060069099 - Fu; Zice ;   et al.
2006-03-30
Imidazolo-related compounds, compositions and methods for their use
App 20060069127 - Fu; Zice ;   et al.
2006-03-30
Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use
App 20060069106 - Fu; Zice ;   et al.
2006-03-30
Asthma and allergic inflammation modulators
App 20040220237 - Fu, Zice ;   et al.
2004-11-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed